In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novian Health Inc.

www.novianhealth.com

Latest From Novian Health Inc.

Market Intel: New Thermal Therapies Blaze Trail In Fast-Growing Cancer Ablation Market

Cancer rates are rising worldwide and as diagnostic techniques continue to improve, new surgical ablation devices are becoming crucial weapons in the growing arsenal of cancer treatment tools. These devices allow doctors to burn away tumors with precision, speed and safety, without the side-effects that patients undergoing radical cancer therapy often experience. This article provides an overview of the cancer ablation market, highlights the key players working on these devices and discusses their potential applications. It also includes critical insights from a leading interventional urologist on the pros and cons of using these various technologies in treating prostate cancer.

Cancer Surgical Procedures

Ablation Therapies Emerging As Gentler Approach To Breast Cancer

Use of ablation technology is emerging as a potentially gentler treatment option for breast cancer, and cryo and thermal ablation in particular are on the verge of regulatory approval that could lead to wider use. A growing number of physicians are already using cryotherapy for breast cancer, but without FDA clearance, reimbursement can be a difficult issue.

Commercial Innovation

Recent Financings Of Private Companies, March 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device

Novian Health Raises $11 Million Series A; Ramps Up Studies Of Breast Cancer Laser Ablation

Novian Health Inc. will use its recent $11 million Series A round to kickstart multicenter clinical trials on its Novilase Interstitial Laser Therapy for ablating early-stage breast cancer.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novian Health Inc.
  • Senior Management
  • Henry R Applebaum, Pres. & CEO
    Eugene A Bajorinas, VP, Operations
    William Graveman, VP, Engineering & Dev.
  • Contact Info
  • Novian Health Inc.
    Phone: (312) 266-7200
    430 West Erie St.
    Ste. 500
    Chicago, IL 60654
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register